GLP-1 drugs may have a beneficial effect across many types of cancer
A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two...
Sources
- news.google.com 4793
- South China Morning Post 52
- hrexecutive.com 18
- U.S. FDA 15
- MedTech Dive 13
- afro.who.int 13
- World Health Organization 13
- japantoday.com 13
- hrdive.com 11
- Nature 9
- hongkongfp.com 5
- nih.gov 2
- 8world.com 0
- asia.nikkei.com 0
- asiaone.com 0
- bangkokpost.com 0
- CNA 0
- Endpoints News 0
- english.kyodonews.net 0
- feeds.bbci.co.uk 0
- fiercehealthcare.com 0
- gov.uk 0
- hsa.gov.sg 0
- japantimes.co.jp 0
- jtimes.jp 0
- koreaherald.com 0
- moh.gov.sg 0
- ntu.edu.sg 0
- nus.edu.sg 0
- singhealth.com.sg 0
- The Business Times 0
- The Straits Times 0
- thehindubusinessline.com 0
- thestandard.com.hk 0
- timesofindia.indiatimes.com 0
- TODAY Online 0
- wwwnc.cdc.gov 0
- news.google.com 4793
- South China Morning Post 52
- hrexecutive.com 18
- U.S. FDA 15
- MedTech Dive 13
- afro.who.int 13
- World Health Organization 13
- japantoday.com 13
- hrdive.com 11
- Nature 9
- hongkongfp.com 5
- nih.gov 2
- 8world.com 0
- asia.nikkei.com 0
- asiaone.com 0
- bangkokpost.com 0
- CNA 0
- Endpoints News 0
- english.kyodonews.net 0
- feeds.bbci.co.uk 0
- fiercehealthcare.com 0
- gov.uk 0
- hsa.gov.sg 0
- japantimes.co.jp 0
- jtimes.jp 0
- koreaherald.com 0
- moh.gov.sg 0
- ntu.edu.sg 0
- nus.edu.sg 0
- singhealth.com.sg 0
- The Business Times 0
- The Straits Times 0
- thehindubusinessline.com 0
- thestandard.com.hk 0
- timesofindia.indiatimes.com 0
- TODAY Online 0
- wwwnc.cdc.gov 0
Japan enacts changes to make childbirth free, raise some patient drug costs
Japan's parliament on Friday enacted health legislation changes to make childbirth free in principle and to raise out-of-pocket costs for some prescription drugs, as the government seeks to...
WHO identifies Ebola treatments, urgesvaccines be tested in trials
The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including ‌Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences…